These additional subcutaneous therapies include deferoxamine, factor, anti-nausea drugs, and monoclonal antibodies. Looking ahead, IHS is exploring breakthrough applications for subcutaneous ...
Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating ...